Immunohistochemistry Market to Grow at a CAGR of 7.4% to reach US$ 3,585.31 million from 2021 to 2028
[Research Report] The immunohistochemistry market is projected to reach US$ 3,585.31 million by 2028 from US$ 2,171.61 million in 2021; it is estimated to register a CAGR of 7.4% from 2021 to 2028.
Market Insights and Analyst View:
Immunohistochemistry (IHC) is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analysed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC. The global immunohistochemistry ihc market size is expected to reach US$ 3,585.31 million in 2028 from US$ 2,1716.1 million in 2021. The market is estimated to grow with a CAGR of 7.4% from 2021-2028.
Growth Drivers and Challenges:
Rising Incidences of Chronic and Infectious Diseases
Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibody for tissue determination and distribution of antigens of particular disease. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases.
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), there were approximately 37.6 million people across the globe with HIV in 2020. Of these, 35.9 million were adults and 1.7 million were children (<15 years old). An estimated 1.5 million individuals worldwide acquired HIV in 2020. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million U.S. residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018.
Diabetes is prevailing at a high rate in the geriatric population worldwide. The prevalence of diabetes is more in overweight and obese people. As per data published by the Center for Disease Control and Prevention (CDC) in 2017, ~30.3 million people, representing 94% of the population of the U.S., are diabetic. Among these, ~23.1 million people are diagnosed with diabetes, while ~7.2 million people have not undergone a proper diagnostic procedure.
The obesity rates have been increasing rapidly in developed as well as developing economies across the globe. Factors such as unhealthy lifestyle and sedentary life are among the major for the rise in the number of obese individuals. As per data published by National Center for Health Statistics (NCHS), the prevalence of obesity is expected to be around 39.8%, affecting about 93.3 million of U.S. adults between the years 2015 to 2016. The incidences of obesity were observed to be significantly high among middle-aged adults (42.7%) as compared to younger adults (35.7%). The increase in the number of obese people in the United States has led to rising healthcare expenditure as well.
Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality worldwide. According to the European Cardiovascular Disease Statistics 2017, every year, cardiovascular disease causes 3.9 million deaths and more than 1.8 million deaths in the European Union (E.U.). The CVD accounts for 45.0% of all deaths in Europe, and 37.0% of deaths in E.U. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which are around half of the U.S. adult population, suffer from cardiovascular disease.
Furthermore, there has been a rise in cancer incidence and mortality rates all over the world, making cancer the leading cause of death. According to the World Health Organization in 2018, approximately 9.6 million deaths around the globe were due to cancer.
Moreover, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the U.S. Similarly, in China, as per the data revealed by WHO, ~4.3 million new cases of cancer were detected as well as 2.9 million cancer deaths were recorded in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the world.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Immunohistochemistry Market: Strategic Insights
Market Size Value in US$ 2,171.61 million in 2021 Market Size Value by US$ 3,585.31 million by 2028 Growth rate CAGR of 7.4% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Immunohistochemistry Market: Strategic Insights
| Market Size Value in | US$ 2,171.61 million in 2021 |
| Market Size Value by | US$ 3,585.31 million by 2028 |
| Growth rate | CAGR of 7.4% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Restraints
Limitations Associated with Immunohistochemistry
Immunohistochemistry employs the specificity of antibodies to detect target molecules among tissues or cells. Moreover, IHC has also proven to be a powerful technique in investigative toxicology. However, some of the limitations associated with the specificity and accuracy of the technique confine its adoption at a certain level.
Lack of specificity of reagents is a problem that is more common than is generally recognized. The lack of specificity may result in tremendous waste in terms of resources and time. Moreover, the application of the technique is also limited by the physical limitations of the antibodies. Furthermore, immunohistochemistry can be misleading if the staining study design is not carefully conceived and controlled.
Although this system is the simplest and the most convenient method for the detection of given marker expression, it is not effectively employed in clinical and research applications due to limitations such as insufficient sensitivity, need for each primary antibody to be individually conjugated with fluorophores or enzymes and staining issues. Thus, the limitations associated with the IHC technique can hamper the market growth to a certain extent.
Report Segmentation and Scope:
The “Global Immunohistochemistry Market” is segmented based on application, product, end user, and geography. The global immunohistochemistry market, based on products, has been segmented into antibodies, equipment, reagents, and kits. The global immunohistochemistry market, based on appplication is segmented into diagnostics and drug testing. In 2021, the diagnostics segment is likely to hold the largest share of the market. Global immunohistochemistry market, based on end user was segmented into hospital & diagnostic laboratories, research institutes, and others. The immunohistochemistry market, based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
Segmental Analysis:
Based on product, has been segmented into antibodies, equipment, reagents, and kits. The antibodies segment is likely to hold the largest share of the market in 2021. Moreover, the reagent segment is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation. Reagents allow researchers to conduct an in-depth analysis of tissues and assays at an exceptional level. Commonly reagents used in immunohistochemistry include histological stains, blocking & fixation reagents, chromogenic substrates, stabilizers, solvents, and proteolytic enzymes, among others. Thermo Fisher Scientific Inc., Abcam plc., and Enzo Life Sciences, Inc., QIAGEN, Bio-Rad Laboratories are some of the major players in this segment. Novel reagents also enable enhanced specifications for the precise and accurate data amount and quality, along with excellent service results Incumbent usage of reagents, growing R&D expenditure, growing government support and technological innovation are among the factors that are expected to strengthen the growth of the reagents segment during the forecast period.
The global immunohistochemistry market, based on application is segmented into diagnostics and drug testing. In 2021, the diagnostics segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe. Diagnosis of the various chronic diseases such as cancer, autoimmune diseases, infectious diseases, and nephrological diseases, among others through immunohistochemistry, have become various efficient. The use of the antibodies, reagents, dyes, and other molecular diagnostics tools makes vital information available quickly and in less period.
The use of immunohistochemistry interprets the diagnosis accurately and offers clinicians with the best therapeutic methods for the treatment. The other advantages of the immunohistochemistry include identification of genetic and molecular causes of a disease that may help in providing the best therapeutic method and patient care. It also helps in the therapeutic applications that enable in evaluating the therapeutic techniques based on the immunological results.
Also, immunohistochemistry techniques are cost-effective than other medical diagnostics. The immunohistochemistry diagnosis utilizes a few hundred dollars as compared to the medical diagnostics. Moreover, technological advancements have made easy availability of antibodies and molecular diagnostics tools. Therefore, owing to the advantages of immunohistochemistry in the diagnosis of diseases, it is estimated that the market is likely to grow exponentially during the forecast period. Global immunohistochemistry market, based on end user was segmented into hospital & diagnostic laboratories, research institutes, and others. In 2021, the hospital & diagnostic laboratories segment is likely to hold the largest share of the market, by end user. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the rise in the prevalence of infectious diseases, cancer and autoimmune disorders. The rise in the cases of these disorders is expected to drive the need for its diagnosis, hence leading to the growth of the segment. Hospitals are among the essential parts of the healthcare system of any country. Technological advancements aid hospitals in diagnosing and treating various disorders such as cardio, neuro, HIV, Hepatitis, oncology, and others. The hospital provides extensive healthcare and medical services to patients suffering from a variety of diseases and disorders. Nowadays, hospitals give better services to their patients. Usually, such hospitals offer diagnostic and treatment services for multiple indications. Enormous patients are admitted for the procedure while several patients walk in for the diagnostics treatment. Among the admitted patients, most of them are already suffering from some disorders. Therefore, to monitor and control their health in real-time, most hospitals are attached to clinical diagnostic laboratories. Thus, hospitals contribute a significant market share to the immunohistochemistry market and are expected to continue the trend during the forecast period.
Diagnostic centers offer a complete analysis of tissue, cell, and body fluid that provide comprehensive diagnostics to ensure the highest quality services and care to patients’ needs. The diagnostic centers have modern diagnostic and pathological equipment and instruments such as biochemistry analyser, haematology analyser, diagnostic test kits, PCR, gel electrophoresis, and others. The pathology and diagnostic centre allow patients to receive a detailed report from the on-site pathologist within few hours to days. For instance, Laboratory Corporation of America Holdings, founded in 1978, is among the leading diagnostic laboratories that offer a full array of pathological and diagnostic services. LabCorp has earned a distinct reputation for quality and compassionate patient care. The advances in pathological technologies providing quick and accurate results in low turnaround time is likely to propel the growth of pathology and diagnostic centers segment over the forecast years.
Immunohistochemistry Market Analysis, Regional Analysis:
Based on geography, the immunohistochemistry market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America is the largest market for immunohistochemistry, and the US, Canada, and Mexico are the major contributors to the market in this region. The growth of the North American market is characterized by the growing prevalence of cancer and corresponding growth in cancer diagnostic tools, technological advancements in immunohistochemistry techniques and rising geriatric population. In addition, growing healthcare expenditure is likely to be a major growth stimulator for the immunohistochemistry market in North America.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global immunohistochemistry market are listed below:
- In July 2021, PD-L1 IHC 22C3 pharmDx of Agilent Technologies Inc. Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC). It is labeled for extended use in patients with NSCLC in the European Union. It can now use in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) 50% for treatment with Libtayo (cemiplimab).
- In April 2020, Bio-Rad launched a blood-based immunoassay kit to detect Covid-19. It is a blood-based immunoassay kit to identify antibodies to the SARS-CoV-2, the virus that causes Covid-19.
- In September 2020, Thermo Fisher and Humanigen agreed to scale up the manufacturing of monoclonal antibodies for COVID-19. This business deal is expected to help scale up manufacturing the California biotech's lenlizumab, a clinical-stage candidate for cytokine storm that the company was testing in severe COVID-19 patients for a possible emergency use approval following this year.
Immunohistochemistry Market Report Scope
Covid-19 Impact:
The breakout of the COVID-19 pandemic in North America had a significant impact on the United States. The country has the highest number of patients who have tested positive. Various healthcare research centers across the country were solely focused on COVID 19 treatments. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global immunohistochemistry market include F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Product, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Asia-Pacific is the lucrative for the immunohistochemistry market.
Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.
Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.
Development opportunities in emerging countries are likely to fuel the market growth in the comping years.
Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.
Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.
Antibodies is the most influencing segment growing in the immunohistochemistry market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunohistochemistry Market – By Product
1.3.2 Global Immunohistochemistry Market – By Application
1.3.3 Global Immunohistochemistry Market – By End User
1.3.4 Global Immunohistochemistry Market – By Geography
2. Global Immunohistochemistry Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing Geriatric Population
5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – Global Analysis
6.1 Global Immunohistochemistry Market Revenue Forecast and Analysis
6.2 Global Immunohistochemistry Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Immunohistochemistry Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Global Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Global Stabilizers Market Revenue and Forecasts to 2028(US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
8. Immunohistochemistry Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus Market
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. Global Immunohistochemistry Market Revenue and Forecasts To 2028– by End User
9.1 Overview
9.2 Global Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Global Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
9.4 Research Institutes Market
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10. Immunohistochemistry Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.1 North America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.2.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.3 North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.3 North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.3.1 North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.1.4 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.5.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.5.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.5.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.5.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.5.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.5.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.5.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.5.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.5.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)
10.1.5.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.5.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.5.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.2 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028
10.2.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.2.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.3.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.4 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.2.5.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.2.5.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.5.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.2.5.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.2.5.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.2.5.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.2.5.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.2.5.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.2.5.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.3 Asia Pacific Immunohistochemistry Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.3.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.3.2 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.4 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.4.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.5 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.3 India Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.6 Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.3.6.6.2.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.3.6.6.2.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.3.6.6.2.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.6.6.3.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.3.6.6.4 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts To 2028
10.4.1 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.2.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.4.2.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.2.3 Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.4.3 Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.4.3.1 Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.4.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.4.5.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.4.5.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.4.5.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.4.5.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4.5.4 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.1 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.4.2.1 Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.4.5.4.2.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.4.5.4.2.3 Rest of Middle East & Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.4.5.4.3 Rest of Middle East & Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.4.5.4.3.1 Rest of Middle East & Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.4.5.4.4 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5 South And Central America Immunohistochemistry Market Revenue and Forecasts To 2028
10.5.1 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.2.1 South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.5.2.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.2.3 South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.5.3 South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.5.3.1 South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
10.5.4 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.5.5.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.1.2.1 Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.5.5.1.2.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.1.2.3 Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.1.3 Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.1.3.1 Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.1.4 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.1 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.2.2.1 Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.5.5.2.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.2.2.3 Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.2.3 Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.2.3.1 Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.2.4 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5.3 Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.5.5.3.1 Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.5.5.3.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.5.5.3.2.1 Rest of South & Central America Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.5.5.3.2.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.5.5.3.2.3 Rest of South & Central America Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.5.5.3.3 Rest of South & Central America Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.5.5.3.3.1 Rest of South & Central America Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.5.5.3.4 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on Immunohistochemistry Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Immunohistochemistry Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Cell Signaling Technology, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abcam plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BIO-RAD LABORATORIES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio SB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Biopharmaceutical Companies
Table 2. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. North America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 8. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 15. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 22. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 24. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 25. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 26. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 27. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 28. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)...................................................................
Table 29. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 30. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn).
Table 31. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn).
Table 32. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn).
Table 33. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn).
Table 34. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 35. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 36. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 37. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 38. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 39. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 40. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 41. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 42. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 43. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 44. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 45. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 46. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 47. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 48. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 49. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 50. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 51. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 52. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 53. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 54. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 55. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 56. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 57. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 58. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 59. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 60. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 61. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 62. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 64. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 65. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 66. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 67. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 68. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 69. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)
Table 70. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)
Table 71. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)
Table 72. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 73. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 74. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 75. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 76. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 77. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 78. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 79. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 80. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 81. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 82. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 83. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 84. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 85. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 86. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 87. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 88. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 89. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 90. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 91. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 92. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 93. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 94. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 95. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 96. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 97. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 98. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 99. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 100. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 101. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 102. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 103. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 104. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 105. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 106. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 107. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 108. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 109. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 110. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 111. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 112. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 113. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 114. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 115. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 116. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 117. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 118. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 119. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 120. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 121. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 122. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 123. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 124. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 125. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 126. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 127. Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 128. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 129. Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 130. Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 131. Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 132. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 133. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 134. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 135. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 136. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 137. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 138. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 139. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 140. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 141. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 142. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 143. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 144. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 145. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 146. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 147. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 148. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 149. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 150. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 151. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 152. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 153. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 154. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 155. Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 156. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 157. Rest of Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 158. Rest of Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 159. Rest of Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 160. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 161. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 162. South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 163. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 164. South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 165. South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 166. South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 167. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 168. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 169. Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 170. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 171. Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 172. Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 173. Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 174. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 175. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 176. Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 177. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 178. Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 179. Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)....................................................................
Table 180. Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 181. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 182. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 183. Rest of South & Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 184. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 185. Rest of South & Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 186. Rest of South & Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 187. Rest of South & Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 188. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 189. Organic Developments Done By Companies
Table 190. Inorganic developments done by Companies
Table 191. Glossary of Terms, Immunohistochemistry Market
LIST OF FIGURES
Figure 1. Immunohistochemistry Market Segmentation
Figure 2. Immunohistochemistry Market Segmentation, By Region
Figure 3. Global Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Product Segment in Immunohistochemistry Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Immunohistochemistry Market, by Geography (US$ Million)
Figure 7. Global Immunohistochemistry Market – Leading Country Markets (US$ Million)
Figure 8. Global Immunohistochemistry Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Immunohistochemistry Market
Figure 15. Global Immunohistochemistry Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Immunohistochemistry Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Immunohistochemistry Market
Figure 18. Global Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 19. Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 20. Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 21. Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 22. Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 23. Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 24. Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 25. Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 26. Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 27. Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 28. Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn).........................................................................
Figure 29. Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 30. Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 31. Global Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 32. Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 33. Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 34. Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 35. Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 36. Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 37. Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 38. Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 39. Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 40. Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 41. Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 42. Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 43. Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 44. Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 45. Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 46. Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 47. Global Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 48. Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 49. Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 50. Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 51. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)
Figure 52. North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 53. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 54. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 55. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 56. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 57. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 58. Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 64. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. Asia Pacific Immunohistochemistry Market Overview, by Country (2018)
Figure 67. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 68. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 69. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 70. China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 71. India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 72. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)
Figure 73. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn).........................................................................
Figure 74. Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Middle East & Africa Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 76. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 77. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 78. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 79. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 80. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 81. Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 82. South and Central America Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 83. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 84. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 85. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)........................................................................
Figure 86. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 87. Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
Figure 88. Impact of COVID-19 Pandemic in North American Country Markets
Figure 89. Impact of COVID-19 Pandemic in European Country Markets
Figure 90. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 91. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 92. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets...........................................................................
Figure 93. Growth Strategies done by the companies in the Market (%)
The List of Companies - Immunohistochemistry Market
- F. Hoffmann-LA Roche AG
- Merck KGaA
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Agilent Technologies
- Bio SB
- Bio-Rad Laboratories
- Cell Signaling Technology, Inc.
- Danaher Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For